VENCLAXTA 50 mg Tablet contains Venetoclax 50 mg. It is an anticancer medicine that belongs to the class of BCL-2 inhibitors. It works by blocking the BCL-2 protein, which helps abnormal cancer cells survive. By inhibiting this protein, Venetoclax promotes the death of cancer cells.
Uses:
Treatment of certain blood cancers, including:
Chronic lymphocytic leukemia (CLL)
Small lymphocytic lymphoma (SLL)
Acute myeloid leukemia (AML) in combination with other medicines as prescribed by an oncologist
Helps reduce the growth and survival of abnormal blood cancer cells.
Dose:
Adults: Dose depends on the type of cancer, treatment combination, and patient's response; prescribed by an oncologist.
Usually started with a gradual dose escalation (ramp-up schedule) to reduce the risk of tumor lysis syndrome.
Take the tablet exactly as directed by the physician.
Swallow the tablet whole with water; do not crush, chew, or break unless advised.
Take with food as instructed by the doctor.
Regular monitoring of blood counts, kidney function, and other laboratory tests is required.
Do not stop or change the dose without medical advice.